Please use this identifier to cite or link to this item:
https://ah.lib.nccu.edu.tw/handle/140.119/105308
題名: | 我國藥品部分負擔經濟效果衡量模型之建立 | 其他題名: | An Economic Model on the Cost Sharing of Prescription Drugs in the National Health Insurance | 作者: | 周麗芳 CHOU, Li-Fang |
貢獻者: | 財政系 | 關鍵詞: | 健康保險;部分負擔;藥品費用 HealthInsurance;CostSharing;Pharmaceeuticals |
日期: | Dec-1999 | 上傳時間: | 22-Dec-2016 | 摘要: | 我國全民健康保險制度在規劃之初,便極為重視部分負擔,舊制部分負擔的課徵範圍包括門診與住院,課徵標準則係總括式,尤其是在門診醫療方面,容易造成非醫師診療的項目(例如檢驗、藥品等)費用增加。全民健保實施四年多來,藥品支出佔總支出的比例有增加的趨勢,因而於民國八十八年八月一日起,新增藥品費用部分負擔;保險對象就醫時,不僅需針對舊制部分負擔繳費,亦需額外繳納藥品費用部分負擔。本文即是針對此項議題,進行經濟效果分析。本文嘗試建立我國門診藥品費用部分負擔經濟效果的衡量模型,並將部分負擔的經濟效果分解為醫療需求抑制效果、保險財務挹注效果及社會福利損失縮減效果。 The cost sharing is an essential instrument of controlling health care cost within the health insurance system.An undifferentiated collection of co-payments, either as a lump sum or at a percentage, is possibly associated with over-proportional increase of non-physician insurance benefits, e.g. the prescribed pharmaceuticals. Thus, a scheme of drug co-payments has been introduced into the National Health Insurance (NHI) in Taiwan on August 1st,1999. This paper is aimed at this issue to conduct an economic analysis. A model is constructed to analyze three economic effects of drug co-payments:containing the demand for medical care, financing the health insurance and reducing the welfare loss. |
關聯: | 國立政治大學學報,80,33-56 | 資料類型: | article |
Appears in Collections: | 期刊論文 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
80-33-56.pdf | 1.43 MB | Adobe PDF2 | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.